US biotech firm completes 95% of dodo genome, targets bird’s possible revival
viaTimes of India15 Oct
Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on…
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Times of India's own reporting rather than reproducing it — the excerpt above comes from Times of India's own feed.
Read the full story on Times of India ↗